fda approval in multiple myeloma, priority reviews in dlbcl and myeloma, and more
Published 6 years ago • 215 plays • Length 8:29
Download video MP4
Download video MP3
Similar videos
-
11:50
fda approval in myeloma, priority review in dlbcl, application accepted of a biosimilar, and more
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
-
10:08
fda approval in waldenstrom macroglobulinemia, priority review and snda in myeloma, and more
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
10:20
fda approvals in myeloma and thyroid cancer, priority review and nda in nsclc, and more
-
9:37
fda approvals in nhl and cinv, priority reviews in melanoma and breast cancer, and more
-
7:07
fda approval in crc, priority review in hcc, encouraging data in myeloma trial, and more
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
10:47
fda approvals in myeloma and itp, applications accepted in myeloma and more
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
9:10
fda approvals in cml and hodgkin lymphoma, priority review in crc, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
8:21
fda approval of a biosimilar, priority review in epithelioid sarcoma, and more
-
0:46
dr. hill on the fda approval of selinexor in dlbcl
-
9:17
fda approvals in cscc, nsclc, and myeloma, breakthrough designation in prostate cancer, and more
-
9:41
asco's cancer advance of the year, fda approval in nets, and more
-
10:01
fda approval in ctcl, breakthrough therapy designation in crc, and more
Clip.africa.com - Privacy-policy